Lialda Tablet, Delayed Release
Product Images NDC 54092-476

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lialda (NDC 54092-476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lialda 01

Chemical structure of mesalamine, the active ingredient in Lialda delayed-release tablets. The structure shows a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*

FDA Label Image

Lialda 02

Lialda 1.2 g delayed release tablets packaging label showing the product name, generic name mesalamine, strength 1.2 g per tablet, and quantity of 120 tablets. The label includes manufacturer Takeda Pharmaceuticals America, Inc., along with storage instructions and warnings. The label also depicts barcodes and the NDC number 54092-476-12.*

FDA Label Image

Lialda 03

Lialda (mesalamine) 1.2 g delayed release oral tablets carton label. The label indicates 1 carton contains 12 bottles with 120 tablets each. It features a green band with the Takeda logo, the product name and strength, and directions that it is once-daily and Rx only. Manufactured by Takeda Pharmaceuticals America, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.